Catabasis Pharmaceuticals to present during the Muscular Dystrophy Association Virtual Clinical Trials Session
March 18, 2020
Erika Finanger, M.D. presents information on Phase 3 development for the treatment of Duchenne muscular dystrophy during the Muscular Dystrophy Association Virtual Clinical Trials Session.